[breadcrumb_custom]

Tag: Dicerna Pharmaceuticals Inc.

Companies

Something To Watch Before Buying Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA)

Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) has a beta of 1.06. The stock’s Relative Strength Index (RSI) is 63.99, with weekly volatility at 6.75% and ATR at

Markets

Is Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) Still Worth A Bite?

Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) has a beta of 1.07. The stock’s Relative Strength Index (RSI) is 66.28, with weekly volatility at 4.88% and ATR at

Companies

Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA): A Fundamentally Weighted Stock for Long-Term Investors

Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) shares traded higher over the last trading session, gaining 3.49% on 05/28/21. The shares fell to a low of $31.27 before

Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.

Quick Links

About Us

Our Team

Disclaimer

Tag: Dicerna Pharmaceuticals Inc.

Something To Watch Before Buying Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA)

Is Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA) Still Worth A Bite?

Dicerna Pharmaceuticals Inc. (NASDAQ:DRNA): A Fundamentally Weighted Stock for Long-Term Investors

Quick Links

Categories